Learn why, for over 20 years, organizations around the world choose INDIGO for their in vitro nuclear receptor screening needs.
Get what you need from the world's largest portfolio of cell-based nuclear receptor reporter assays
INDIGO has the largest portfolio of cell-based nuclear receptor assays in the world. Our luciferase assays help you identify compounds with the highest selectivity and the lowest potential for unwanted effects and off-target responses. Our broad portfolio of nuclear receptors makes us the preferred source for single receptor or full-panel screenings. Whether for nuclear receptor or in vitro toxicology solutions, our intellectual property, ease of use, and quick turnarounds will get you the data you want, faster. Check out our portfolio of all-inclusive cell-based assays.
Make confident decisions with clear results about your compounds
INDIGO’s luciferase reporter technology provides increased sensitivity and precision allowing INDIGO assays to generate clear single receptor or full-panel screening results, making for better interpretation and more accurate data. Employing a luminescence-based method and our proprietary CryoMiteTM preservation process, our assay kits provide reproducible results lot-to-lot, and our comprehensive lab services include reports with helpful graphics, summaries, and insights.
Be supported in your study with a committed team of experts
INDIGO is a leading provider of cell-based nuclear receptor reporter and in vitro toxicology assays and we are recognized for our focus on client support. Our team goes the extra mile by offering complimentary study consults, designs, and research, and provides a comprehensive review of the results. As objective experts focused on your success, it’s our duty to ensure the results we provide inform assured next steps. Learn more about our reporter assay services.
Save time and money with accelerated lab results and decisions
At INDIGO, our cell-based assay kits and services accelerate scientific decision-making by reducing time, cost, and risk associated with the discovery process. We know that time is money during discovery and aim to get you to the next phase faster or prevent unnecessary steps forward. For quick data and decisions, our kits deliver results in as little as 24 hours. And, beyond saving time, our kits and services also provide the most comprehensive data for your investment.
Screen your compounds using reliable science, platforms, and people
INDIGO provides a superior combination of expertise, kits, services, and support to organizations around the globe, ranging from Governmental Organizations, Academic and University Labs to Pharmaceutical, Biotech, and Contract Research Organizations. Organizations trust us for single receptor or full-panel screenings, leveraging our industry-leading platforms, knowledgeable people, and proprietary science.